EPS is irrelevant at this stage, growth rates are important, and NPAT is growing 60-100%.
On a full year basis, earnings should be 0.3 cents, placing the company on a PE around 25. Thats more than reasonable for the current growth. I just purchased at 6f.7 cents on the above basis, and that 67m turnover should have absorbed the majority of the 46m SPP shares that people are unloading. Possibly a 7.1 cent close once the fear subsides and fundamentals take hold.
- Forums
- ASX - By Stock
- lol beware - classic pump and dump occurring
JUM
unknown
EPS is irrelevant at this stage, growth rates are important, and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online